透過您的圖書館登入
IP:3.149.251.155
  • 期刊

接受自體造血幹細胞移植腦瘤病童之照護

Nursing Care of Children with Brain Tumor Undergoing Autologous Hematopoietic Stem Cell Transplantation

摘要


自體造血幹細胞移植應用於腦瘤病童除了增加長期存活率外,也藉此讓病童成長至3歲後再接受放射線治療,以減少因腦部放射治療造成長期內分泌異常及生長發育、學習力、自我照顧能力的障礙。接受自體造血幹細胞移植的腦瘤病童平均年齡較小,照護過程端賴護理人員的審慎評估,早期發現移植併發症並處理。為增加臨床人員的照護知能,進行文獻查證,除簡述兒童腦瘤種類、治療方式、自體造血幹細胞移植流程及移植期間照護重點,更闡述接受造血幹細胞移植病童家庭所承受之衝擊,期能提升病童的生活品質。

並列摘要


As medical technology continues to improve, autologous hematopoietic stem cell transplantation (auto-HSCT) for children who received myeloablative chemotherapy can increase long-term survival rate. Whole brain radiation for brain tumor patients younger than 3-year-old often causes growth retardation and decreases learning ability. Myeloablative chemotherapy with auto-HSCT can delay the need for whole brain radiation. The average ages of patients who undergo auto-HSCT are younger. The nursing staffs need to evaluate their clinical conditions carefully in order to detect and manage any complication early. In this article, we introduce different types of brain tumor standard therapies and the critical point of clinical care. We also mention the impact to the families of patients undergoing auto-HSCT. The aim of this article is to improve the quality of nursing care via the enhancement of care knowledge among nursing staff.

參考文獻


丁玉佩、呂佩珍 (2009).一位急性骨髓性白血 病患者接受幹細胞移植之護理經驗. 志 為護理 ,8(2),102-110。
王玉祥 (2000).造血幹細胞移植的演進. 臺灣 醫學 ,4(2),177-186。
李宜燕、顏秀如、洪君儀、邱宗傑 (2010).以 高劑量化療配合自體幹細胞移植治療兒 童復發性中樞神經系統的惡性腫瘤. 中 華民國血液病學會 & 中華民國血液及骨 髓移植學會聯合會訊 ,99(3),15 -20。
吳沾、邱宗傑 (2006).病童接受造血幹細胞移 植家庭之壓力經驗. 中華民國血液病學 會 & 中華民國血液及骨髓移植學會聯合 會訊 ,95(1),19-22。
洪惠青、張正雄、鍾智淵 (2003).自體周邊 血液幹細胞之收集與冷凍保存及應用於 臨床自體周邊血液幹細胞移植:彰化基 督教醫院經驗.The Changhua Journal of Medicine,8(3),155-160。

延伸閱讀